Article info
Aetiology/Harm
Cohort study
Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin
- Correspondence to : Dr John W Eikelboom, McMaster University, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario, Canada L9K 1H8; eikelbj{at}mcmaster.ca
Citation
Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin
Publication history
- First published April 13, 2015.
Online issue publication
May 22, 2015
Article Versions
- Previous version (13 April 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions